Correlation Between Evolus and Valeo Pharma
Can any of the company-specific risk be diversified away by investing in both Evolus and Valeo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Valeo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Valeo Pharma, you can compare the effects of market volatilities on Evolus and Valeo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Valeo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Valeo Pharma.
Diversification Opportunities for Evolus and Valeo Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Evolus and Valeo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Valeo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valeo Pharma and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Valeo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valeo Pharma has no effect on the direction of Evolus i.e., Evolus and Valeo Pharma go up and down completely randomly.
Pair Corralation between Evolus and Valeo Pharma
If you would invest 4.69 in Valeo Pharma on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Valeo Pharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Evolus Inc vs. Valeo Pharma
Performance |
Timeline |
Evolus Inc |
Valeo Pharma |
Evolus and Valeo Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evolus and Valeo Pharma
The main advantage of trading using opposite Evolus and Valeo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Valeo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valeo Pharma will offset losses from the drop in Valeo Pharma's long position.Evolus vs. Crinetics Pharmaceuticals | Evolus vs. Enanta Pharmaceuticals | Evolus vs. Amicus Therapeutics | Evolus vs. Connect Biopharma Holdings |
Valeo Pharma vs. Lowell Farms | Valeo Pharma vs. cbdMD Inc | Valeo Pharma vs. Evolus Inc | Valeo Pharma vs. Avant Brands |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |